These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 6603675

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Antithrombotic and haemorrhagic effects of synthetic and naturally occurring thrombin inhibitors.
    Kaiser B, Markwardt F.
    Thromb Res; 1986 Sep 15; 43(6):613-20. PubMed ID: 3764808
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological characterization of a new highly effective synthetic thrombin inhibitor.
    Kaiser B, Hauptmann J, Weiss A, Markwardt F.
    Biomed Biochim Acta; 1985 Sep 15; 44(7-8):1201-10. PubMed ID: 4084272
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of heparin, hirudin, and a synthetic thrombin inhibitor on antithrombin III in thrombin-induced disseminated intravascular coagulation in rats.
    Hauptmann J, Brüggener E, Markwardt F.
    Haemostasis; 1987 Sep 15; 17(6):321-8. PubMed ID: 3428717
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparative study on the antithrombotic effects of a synthetic thrombin inhibitor and of heparin in animal models.
    Hauptmann J, Barth A, Schönberger FP, Markwardt F.
    Biomed Biochim Acta; 1983 Sep 15; 42(7-8):959-65. PubMed ID: 6651812
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Biliary excretion of synthetic benzamidine-type thrombin inhibitors in rabbits and rats.
    Hauptmann J, Kaiser B, Paintz M, Markwardt F.
    Biomed Biochim Acta; 1987 Sep 15; 46(6):445-53. PubMed ID: 3675563
    [Abstract] [Full Text] [Related]

  • 10. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP, Bernat A, Gaich C, Herbert M.
    Thromb Haemost; 2002 Feb 15; 87(2):238-44. PubMed ID: 11858483
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Proceedings: Animal experiments of a new synthetic thrombin-inhibitor, dansyl-arginine-methyl-piperidine amide.
    Hijikate A, Okamoto S, Ikezawa K, Kikimoto R, Tonomura S, Tamao Y.
    Thromb Diath Haemorrh; 1975 Sep 30; 34(1):347-8. PubMed ID: 1188794
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of thrombin active site and exosite inhibitors and heparin in experimental models of arterial and venous thrombosis and bleeding.
    Schumacher WA, Steinbacher TE, Heran CL, Seiler SM, Michel IM, Ogletree ML.
    J Pharmacol Exp Ther; 1993 Dec 30; 267(3):1237-42. PubMed ID: 8263785
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological studies on the antithrombotic action of hirudin in experimental animals.
    Markwardt F, Hauptmann J, Nowak G, Klessen C, Walsmann P.
    Thromb Haemost; 1982 Jun 28; 47(3):226-9. PubMed ID: 7112494
    [Abstract] [Full Text] [Related]

  • 15. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
    Freund M, Mantz F, Nicolini P, Gachet C, Mulvihill J, Meyer L, Beretz A, Cazenave JP.
    Thromb Haemost; 1993 May 03; 69(5):515-21. PubMed ID: 8322274
    [Abstract] [Full Text] [Related]

  • 16. Antithrombotic activity in vivo of SDZ 217-766, a low-molecular weight thrombin inhibitor in comparison to heparin.
    Tapparelli C, Metternich R, Gfeller P, Gafner B, Powling M.
    Thromb Haemost; 1995 Apr 03; 73(4):641-7. PubMed ID: 7495072
    [Abstract] [Full Text] [Related]

  • 17. The influence of drugs on disseminated intravascular coagulation (DIC). II. Effects of naturally occurring and synthetic thrombin inhibitors.
    Markwardt F, Nowak G, Hoffmann J.
    Thromb Res; 1977 Sep 03; 11(3):275-83. PubMed ID: 918899
    [No Abstract] [Full Text] [Related]

  • 18. Comparative antithrombotic potencies of direct thrombin inhibitors and low-molecular-weight heparins in an ex vivo human experimental thrombosis model.
    Harenberg J, Zokai K, Piazolo L, Fenyvesi T, Jörg I.
    Semin Thromb Hemost; 2002 Aug 03; 28(4):379-82. PubMed ID: 12244485
    [Abstract] [Full Text] [Related]

  • 19. Nonpolar interactions of thrombin and its inhibitors at the fibrinogen recognition exosite: thermodynamic analysis.
    Cheng Y, Slon-Usakiewicz JJ, Wang J, Purisima EO, Konishi Y.
    Biochemistry; 1996 Oct 08; 35(40):13021-9. PubMed ID: 8855937
    [Abstract] [Full Text] [Related]

  • 20. Experimental pharmacology of hirunorm: a novel synthetic peptide thrombin inhibitor.
    Cirillo R, Lippi A, Subissi A, Agnelli G, Criscuoli M.
    Thromb Haemost; 1996 Sep 08; 76(3):384-92. PubMed ID: 8883275
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.